On 22 January, 2020, the Ministry of Food and Drug Safety made open useful data: Pharmaceutical products to which patent rights ceased to exist but no generic competition. The data was retrieved from the “Green List” for linkage patents in Korea (FYI, EPO provides a guideline on how to search the Green List in English, …